Hello, everyone. Thank you for joining us, and welcome to Toyo's third quarter and first nine months 2026 financial results conference call. After today's prepared remarks, we will host a question-and-answer session. If you would like to ask a question, please press star one to raise your hand. To withdraw your question, press star one again. I will now hand the conference over to Crocker Coulson. Crocker, please go ahead.
Thank you, Matt. Hello, everyone. Thank you so much for joining us to review Toyo's third quarter and first nine months 2026 results. This morning, Toyo posted both the earnings release and a related investor presentation to our website, which you can find at investors.toyo-solar.com. With us today on the call are Takahiko Onozuka, Toyo's Chairman and Chief Executive Officer, Rhone Resch, Toyo's Chief Strategy Officer, and Yasunari Harada, Toyo's Chief Financial Officer. We also have Simon Shi, Senior Advisor to the Board, who will be available during the Q&A portion of this call.
After the prepared remarks are concluded, we are going to open up this call for your questions. Before we begin, the financial results discussed on this call for the third quarter of 2026 and the first nine months of 2026, and the corresponding periods of 2025, are unaudited, and some statements in this teleconference are forward-looking within the meaning of federal securities laws. These include statements about our module business outlook, expected solar module deliveries and solar cell supply, the resumption of sales to U.S. customers, our HJT cell line, the Section 232 program, and our discussions with Department of Commerce, and the Commerce circumvention inquiry.
Although we believe these statements are reasonable, we can provide no assurance that they will ultimately prove to be accurate because they are prospective in nature. During this call, we will also discuss certain non-GAAP financial measures, such as adjusted EBITDA and adjusted net income. Reconciliations to the most directly comparable GAAP measures are included in our earnings release.
Actual results could differ materially from those we discuss today. We therefore encourage you to review our most recent annual report on Form 20-F, Form 6-K, and other SEC filings for risk factors that could materially impact our results. With those formalities out of the way, it is now my great pleasure to turn this call over to Onozuka-san, Toyo's Chairman and CEO. Onozuka-san, please take it away.
Thank you, Crocker. In the third quarter, U.S. trade proceeding affecting solar cells from our Ethiopia facility disrupted our cell business. Even though we remain profitable, third quarter revenue increased 57.3% year-over-year, and our U.S. module business continued to expand. For the first nine months, revenue increased 42.0%, and net income nearly doubled. We also made real operational progress. We completed our second module line in Humble, Texas, bringing capacity there to approximately 2 GW, and we marked milestone at our October 6 ribbon cutting and Solar Analyst Day.
Rhone will take you through our trade proceeding and the U.S. module business, and our CFO, Harada-san, will review the financials in detail. We remain committed to full transparency in our supply chain and to build a long-term manufacturing platform in the United States. I will now turn the call over to our CSO, Rhone Resch.
Thank you, Onozuka-san, and good morning, everyone. I will focus on four areas that are central to Toyo's strategy in the United States: the continued growth of our U.S. module business, the Section 232 process, our planned HJT cell investment in Texas, and the trade proceedings affecting cells produced in Ethiopia. Taken together, these developments show how Toyo is executing on a clear strategy, expanding U.S. manufacturing, building a more transparent and resilient non-FEOC supply chain, and reducing our exposure to the trade uncertainty affecting imported solar products.
Our opportunity is significant. Demand for domestically manufactured solar products continues to strengthen. U.S. policy is increasingly supporting onshore production, and Toyo is positioning itself to participate in that transition at scale. Let me begin with our U.S. module business, which continues to be an important source of growth and increasingly provides greater visibility into our future revenue.
As Onozuka-san mentioned, on October 6, we held a ribbon-cutting ceremony and Solar Analyst Day at our Houston area facility in Humble, Texas, marking the completion of our expansion to approximately 2 GW of module manufacturing capacity. We were honored to be joined by Jeffrey Kessler, Under Secretary of Commerce for Industry and Security, Takeshi Koyama, Consul General of Japan in Houston, Congressman Christian Menefee, and Paul Wormser of Intertek CEA, along with customers, partners, analysts, and investors. It was really a fun event. For Toyo, this expansion represents an important milestone. We now have a meaningful U.S. manufacturing platform operating at scale, supporting by a growing workforce, strong customer demand, and continued engagement with federal, state, and local stakeholders. Our U.S. module business continues to expand during the third quarter.
We delivered 277.4 MW of modules during the quarter and 469 MW during the first nine months of the year. With our second production line now complete, our Houston area module facility has approximately 2 GW of nameplate capacity. Importantly, customer demand is translating into contracted business. Since mid-June, we have entered into multiple binding module supply agreements with U.S. customers, representing an aggregate value of approximately $240 million. Deliveries began during the third quarter and are scheduled to continue through the first half of 2027.
This gives us meaningful visibility into our U.S. module business as we enter 2027. We have also taken steps to protect these customer commitments from the trade uncertainty affecting our Ethiopian cell operations. We have secured non-FEOC cell supplies from outside Ethiopia sufficient to support our committed U.S. module deliveries through 2027. That is an important point for investors.
While the trade proceedings have created uncertainty for our cell business, they have not stopped the continued ramp of our U.S. module operations or our ability to meet our committed customer deliveries. As I mentioned, demand for U.S. modules supported by a transparent, non-FEOC supply chain remains strong, and that is exactly the manufacturing platform that we are building in Texas. Turning to trade policy, on August 6, the President issued a Section 232 proclamation covering imports of polysilicon and downstream solar products. We believe this action reinforces the importance of developing a stronger domestic solar manufacturing base and is closely aligned with Toyo's long-term strategy in the United States.
Toyo has submitted a proposal to the Department of Commerce for an offset agreement designed to support our multi-year U.S. investment plan, including our planned HJT facility and the potential expansion of our U.S. manufacturing footprint into upstream solar products.
We are currently engaged with Commerce regarding the terms of that proposal. Any agreement, including eligible products, volumes, timing, and other conditions, remains subject to Commerce's approval, and we therefore cannot quantify the potential financial impact at this stage. However, the strategy objective is clear. We want to align Toyo's substantial U.S. manufacturing investment with U.S. trade policy in a way that accelerates domestic production and strengthens the U.S. solar supply chain.
Polysilicon sourcing is an important part of that strategy. For products serving the U.S. market, we currently source polysilicon entirely from non-Chinese suppliers, including suppliers in the United States and OCI in Malaysia. U.S.-produced polysilicon represents the majority of the polysilicon that we use for our Ethiopian cell plant. This supports our broader objective of building a supply chain that is increasingly anchored in the United States and with allied countries.
Our next major step in that strategy is domestic solar cell manufacturing. We continue to develop a 1.5 GW heterojunction, or HJT, solar cell line at our Houston area site in Humble, Texas. The planned investment is approximately $357 million, and we continue to expect pilot production no later than the first quarter of 2028. We recognize that investors will naturally focus on the capital requirements associated with a project of this scale. The timing and pace of the investment will remain aligned with non-dilutive financing, availability, and other capital resources. We intend to pursue the project in a disciplined manner while maintaining appropriate liquidity for our existing operations. Strategically, this facility is very important for Toyo.
It will bring next-generation cell manufacturing and R&D onto the same U.S. campus as our module operations and further reduce our reliance on imported cells. It is also a central component of the broader U.S. manufacturing plan we are discussing with the Department of Commerce. Our objective is not simply to assemble modules in the United States. Over time, we intend to build a more integrated U.S. manufacturing platform around advanced solar technology. Let me now address the trade proceedings affecting our Ethiopian operations. During the third quarter, shipments of solar cells from our Ethiopian facility were affected by U.S. Customs and Border Protection examination.
We worked closely and cooperatively with CBP and provided detailed information regarding our supply chain. I am pleased to report that all shipments affected by that examination have now been released, and we are pursuing certification under CBP's Customs Trade Partnership Against Terrorism, or CTPAT, a program that further strengthens the security and transparency of our supply chain. Excuse me.
However, the release of those shipments does not resolve the separate U.S. Department of Commerce circumvention inquiry concerning solar cells completed in Ethiopia, which was initiated on July 17th of this year and remains ongoing. Our U.S. module operations remain protected. As I mentioned earlier, we have secured non-FEOC cell supply from outside Ethiopia sufficient to meet our committed U.S. module deliveries through 2027. That allows us to continue serving our U.S. customers while the Commerce process proceeds. Now I want to talk a little bit about the anti-circumvention inquiry.
As I mentioned, on July 17th, the Department of Commerce initiated a countrywide circumvention inquiry concerning certain solar cells and modules completed in Ethiopia using parts or components from China. Thankfully, Commerce selected TOYO as a mandatory respondent, and we have submitted our initial questionnaire response. That submission provides detailed information regarding our sourcing, investment, manufacturing operations, and the value added through our production process in Ethiopia. We are cooperating fully with Commerce and will continue to provide all information required as part of its review. One important fact in TOYO's case is that we do not use Chinese-origin wafers in our Ethiopian cell production.
The use of Chinese-origin wafers and other Chinese components was a significant factor in prior solar circumvention proceedings, making our wafer sourcing an important distinction in the factual record. Ultimately, Commerce will evaluate the complete record, and we cannot predict either the outcome or the timing of the inquiry. We remain confident in the facts supporting TOYO's supply chain and will continue to work constructively with Commerce throughout the process.
As we move forward, our priorities are clear: deliver on our contracted U.S. module business, maintain transparent and traceable supply chains, manage trade risk carefully, and continue expanding advanced manufacturing in the United States. Despite the trade uncertainty affecting our cell business, we are building a larger, more diversified, and increasingly U.S.-based manufacturing platform. We believe that positions TOYO well for the direction in which both the market and U.S. policy are moving. I will now turn the call over to our CFO, Yasunari Harada, to review our financial results in more detail. Harada-san?
Thank you, Ron. Third quarter revenue was $129.0 million, down 4.8% from $135.6 million a year earlier, and up 9.2% from the second quarter of 2026. By product, cell sales were $49.4 million, module sales, $55.4 million, and wafer sales, which began in July, $24.3 million. Third-party revenue grew 57.3% to $112.1 million, and related party revenues was $17.0 million. Cost of revenues was $107.6 million, up from $100.8 million. Gross profit was $21.5 million, for a gross margin of 16.6%, compared with a 25.7% a year earlier, and 31.3% in the second quarter. The decrease in gross margin mainly reflected the change in our sales mix, as solar cell sales decreased and solar module sales increased.
Our solar module business continued to generate double-digit gross margin. Income tax expense was $0.6 million, down from $5.8 million, reflecting lower taxable income and preferential 5% rate for our Singapore subsidiary, effective June 1st, 2026. Net income was $4.3 million versus $22.6 million a year earlier. Non-GAAP adjusted EBITDA was $19.5 million, and adjusted net income was $4.5 million.
Basic and diluted EPS were $0.10, compared with $0.66. Turning to the first nine months of 2026, revenue was $390.0 million, up 42.0% from $274.7 million a year earlier. Growth came mainly from module sales of $101.2 million, OEM service revenue of $37.2 million, and the new wafer sales partly offset of lower cell sales. Gross profit was $106.2 million, up 83.4% from $57.9 million, for a gross margin of 27.2%, compared with 21.1% a year earlier. Operating expenses were $42.1 million, compared with $19.5 million, reflecting additional staff at our Ethiopia and Texas plants, and higher legal and professional fees related to trade and regulatory matters.
Net income was $50.1 million, up 99.5% from $25.1 million. Non-GAAP adjusted EBITDA was $102.1 million, and adjusted net income was $50.7 million. Basic EPS was $1.27, and diluted EPS was $1.26, compared with $0.66 a year earlier. On the balance sheet, we ended the quarter with $74.0 million in cash and restricted cash, including $64.9 million of unrestricted cash, up from $58.9 million at year-end. Nine months operating cash flow was $35.2 million, and we invested $44.1 million in property and equipment.
With our Houston solar module capacity substantially committed for 2027, we expect our Texas solar module operation to operate at or near full capacity next year. Given the continuing uncertainty related to the Commerce circumvention inquiry and the Section 232 program, which principally affects cell shipment, we are not providing quarterly guidance for our solar cell business, specific guidance on revenue, net income, or other metrics at this time. That concludes the financial review. Thank you.
Operator, I think we are ready for the question-and-answer session. We will now begin the question-and-answer session. If you would like to ask a question, please press star one to raise your hand. To withdraw your question, press star one again. We ask that you pick up your handset when asking a question to allow for optimum sound quality. If you are muted locally, please remember to unmute your device. Please stand by while we compile the Q&A roster. Your first question comes from the line of Amit Dayal with H.C. Wainwright. Amit, your line is open. Please go ahead.
Thank you. Good morning, everyone, and congrats on a pretty solid quarter despite some of the export controls issues you are navigating. My question on that front is there any one type of determination that the CBP will make that will allow you to get out of this overhang a little bit? Or are you just navigating this process as the CBP sort of undergoes its own diligence on this? How should we think about how this potentially gets resolved for you going into 2027?
Yeah. Thanks, Amit.
Let me take that one and maybe distinguish between CBP and the circumvention, just to make that clear for the listeners.
Yeah, exactly. Thanks, Crocker. Good morning, Amit. The CBP process is fairly straightforward. They are evaluating if any forced labor was used in the production of solar cells. Most of the companies who import into the U.S. go through this process. It takes time. You have to obviously produce information that not only shows your supply chain, but from your suppliers, your polysilicon suppliers, the information all the way back to where the quartzite was actually mined, right?
There are many different participants in this process that provide information to CBP. It does take a little bit of time. We have obviously a very close relationship with our polysilicon providers. They have gone through this process before. They provided all the information to CBP. We have met with CBP multiple times, both in person and on Zoom calls. We have been very open and transparent with them on all the information that they are looking for. I would say that we have developed a very clear line of communication.
We have very clear controls within the company. We are very disciplined about tracking and having the information available on all of our supply chain. In this case, we provided it to them. CBP has released all of the detentions that we had. Again, I would say ongoing, we are going to continue to provide them with any information that they have, but there are no detentions at this point. As I mentioned, we are applying for the CTPAT process. It is fairly rigorous. Very few solar manufacturers in the U.S. have it, but we are committed to it.
That CTPAT process, again, shows not only a commitment by the company for transparency as well as compliance, but also establishes a, let's say, a different level of certification with CBP once you achieve it. As a company, we are very committed to continuing to work with CBP and make that information available, of course. The second issue is around the circumvention case, and this is separate.
This was a case that was filed by a group of companies led by First Solar, and was initiated on July 17th. The circumvention case goes through the process where the Department of Commerce sends out a questionnaire to mandatory respondents. Thankfully, we are a mandatory respondent. It gives us a chance to be very open and transparent in providing information about our manufacturing process, our supply chain, et cetera.
Commerce sends a comprehensive questionnaire, which we just completed last week. They will then review that questionnaire and then have follow-up questions. At least at this point in time, they are scheduled to have a preliminary determination by December 17th. We cannot really speculate on timing. They often do delay. I think what is clear in this process is that this is not the first circumvention case. There have been multiple cases over time since the original 2012 AD/CVD case in China, Solar one, which you will remember, Amit. In all of those cases, the determining factor was where the wafer originated from. If you were using a Chinese wafer, you were subject to tariffs. If you were using a non-Chinese wafer, you were not. Those were the previous cases.
Again, we cannot determine exactly how Commerce will go about this case, but it is pretty straightforward. It is another circumvention case. From Toyo's perspective, we do not use Chinese wafers at our facility in Ethiopia. All of them come from Indonesia. All of the polysilicon is either U.S. or coming from OCI in Malaysia. We will continue to work with the Department of Commerce to provide them whatever information that they need, in obviously a timely manner, and we will continue to be very, let us just say, involved in that whole process. Does that answer your question, Amit?
Yes, yes. Thank you for that clarification. That is very helpful, actually. Let me kind of have some kind of a date also to work with on this. I appreciate that. Then, for the 1.5 GW HJT capacity coming into play, I guess you are saying potential production in Q1 2028. Should we assume the long lead time equipment, et cetera, orders for those have already been placed and work to begin sort of setting up that line is already underway? How should we think about the phased CapEx going into sort of bringing that capacity online?
Sure. I will take the first cut at that as well, and if Harada-san or Simon wants to jump in as well. Yes, we have secured the equipment for the facility. We are now at the Houston plant, going through the process of permitting. We need more power. We need more water. I think you have been to the facility. It is 567,000 sq ft. It is a very large facility. We have plenty of room for the 1.5 GW plant to be built there. So we are certainly on schedule. I think, Amit, the one point that I would like to make just about the company overall is we have built cell facilities before, right? We built them in Vietnam.
We built them in Ethiopia. We have that experience of designing, constructing, and ramping cell facilities. It is not that easy, as many companies are finding out. Specifically, Toyo has executed in our ability to do this in the past. When we look kind of in general about the funding for the HJT plant, we are going to do so in a non-dilutive manner to the greatest extent possible. We believe that we have sufficient operating cash flow from the business.
We expect Section 45x tax credits to be an important source of the funding for the HJT line, along with debt financing, operating cash flow, and other non-dilutive sources. So, as we are kind of looking forward to this particular facility, it actually fits in, I think, very nicely with the policy structure that has been created, both with respect to tax credits, but also the onshoring program. As we look at the 232 structure, the HJT plant is a big part of our proposal to the Department of Commerce. I will leave it there, and if you have any additional questions about the HJT line, I will let you dive in deeper.
No, that was helpful. Thank you. My last question, I guess, is, as you are sort of indicating full capacity utilization for 2027, how should we think about the third-party portion of that capacity utilization? What could third-party revenues look like in 2027 relative to this year?
When you say third party, what do you mean, Amit, in that context?
From your breakdown—
Are you talking about the mix of third party versus internal?
Yeah.
Is that what you're talking about?
Yes, yes.
I think maybe, I don't know, Simon, are you on? Do you want to opine on that?
Yes. Yeah, sure. Thanks, Amit. Thanks for the question. Actually looking to 2027, I would think almost all of our revenue will be from third party.
Okay, understood.
Can we expect to have all the shipments from—
I mean—
Yeah, I mean. Yes.
Great. Amit, does that answer your questions?
Yes, I got it.
Yeah.
Yeah.
Okay, got it.
I think we want to agree with you. Yeah.
Great. Operator, I think we have another person in queue.
Your next question comes from the line of Philip Shen with Roth Capital Markets. Philip, your line is open. Please go ahead.
Hey, guys. Thanks for taking my questions. I wanted to dig into the detention situation a little bit more. Just more color on, you guys talked about shipments have been released, but can you give us some color on, have all shipments been released? Are any shipments still being detained? How is the flow of material or cells right now? If product is still detained, what is the timeline of that release? Do you expect that eventually no product will be detained and when that might be? Thanks.
Sure, I will jump. This is Rhone. Good morning, Phil. What I want to do is kind of talk a little bit about CBP and the circumvention case together, because they do kind of play, obviously, from a supply perspective, into our U.S. imports. From CBP, everything has been released. There were not huge volumes of cells, but once you start to have cells detained from CBP, obviously it starts to restrict your flow. So we worked obviously very closely with CBP over a three, almost four-month timeframe to get them released.
That was actually quite fast with respect to the process that CBP goes through. So we have a very clear, transparent line of communication about our imports. We obviously have a very clean line of supply chain with respect to our polysilicon, where it is mined, who has produced. We expect that CBP will continue to ask questions and look at various import shipments from time to time. At this point in time, the detentions from CBP are not a restriction for us. Okay? Everything is released. The restriction is more on the lines of the uncertainty associated with the circumvention case.
Because that is sitting out there is uncertainty as to if those imports from Ethiopia would be tariffed or not. So we are not bringing in cells because of that uncertainty. We are working closely with Commerce, as I mentioned. We have submitted our questionnaire. We are having direct communication with them to try to get some clarity with respect to this particular case. At this point in time, the detentions, or I should say the imports are not affected by the CBP detention. They are more being impacted by the uncertainty associated with the circumvention case.
Great. That clarifies it for me. Thank you, Rhone. You guys mentioned on your call or your remarks earlier that you have enough cells imported to meet your 2027 demand. So wanted to connect with you on what does that mean for, can you sketch out what 2027 financially might look like? If you need to bring in more cells, what would that be for 2028? Thanks. Simon, do you want to talk a little bit about the cell supply? Our cell supply, it meets our commitments from all of our customers today. Yeah. Go ahead, Simon.
Yeah, that is correct, Phil. Actually, if you look in our book, I think what's reflected in the book is a rapid build-up of our prepayments and working capital, which are used towards to support the shipment commitment of our Houston module factory next year. That, to simply address your question, I think we are already looking to full operation or nearly full operation for next year for our capacity in Houston module manufacturing next year.
That's already being supported by our raw material supply chain. So we are very confident about the shipment and our performance for next year, Phil. You just mentioned about 2028. Hopefully, starting from 2028, as we plan, we will have our Houston-made cells coming out to support our manufacturing Houston modules too.
I think the other piece is—
Okay, thank you, John.
We'll have clarity on the circumvention case, obviously, then we'll be able to import from Ethiopia fully, right? That's a 4 GW cell line as well. I think by 2028, obviously, we'll have both production domestically as well as greater imports from our Ethiopian facility.
Great. Thank you. Then just an update on the Commerce preliminary determination. Are you guys still expecting December 10th for the preliminary determination there? Can you just give us an update on the timeline of the AD/CVD? Has any of that changed? Thanks.
Well, that's certainly kind of, at least statutorily, what they're required to do. We fully expect, and they're moving forward, right, with respect to the questionnaires, responding to our answers. The process is usually kind of back and forth at this point, Phil, so they will come back with additional questions, we'll answer them. We would expect that they would stick to that deadline. However, as we've seen in other cases, sometimes it does get delayed. They're a little bit understaffed. We do not have any clarity from them about a schedule other than what they are required to do statutorily, which is, as you mentioned, December 10th.
Okay, got it. Thanks. From a customer standpoint, can you give us a sense for how those discussions are going? How much of 2027 modules or module capacity remains to be available to be booked? It sounds like you're mostly sold out for next year, but if you can give us a rough percentage, that would be great. Can you talk about module pricing? How has that changed in the past two or three months since the August polysilicon Section 232 announcement came out? Thanks.
Phil, let me take this one. First of all, we, like I said, we have either already sold or in the process of selling for the capacity of next year from Houston. We do reserve a very limited buffer for the new orders to come in, or to reflect with a price to be more reflective to the market demand. Back to your question, I think current order book and current sales opportunity already fill up all our capacity for next year. But we do have, let's say, less than 20% capacity, which we reserve, even though it's already backed by the demand or sales opportunity we see, but we're not rushing into signing the contract at the moment. On the top of that, the price is going up with the Section 232 policy.
We are looking to mid-$0.30s for the sales for next year, early next year, and to high $0.30s for the rest of next year, in terms of shipment timing.
Okay. This is already priced in, like contractually. Mid-$0.30s for the first half of next year's sales volume, and then high $0.30s per watt for the back half of next year, correct?
That is correct. That's the current orders we are taking. But like I said, we do keep a small portion in hand, hopefully, to see a better sales or commercial opportunity in the future.
Okay. Great. Thank you. Have you started negotiating 2028, and where's the price for an imported cell and U.S.-made module there?
Mm-hmm. I think 2028 will be more reflecting of the 232 policy, which will be over $0.40. That's the range we're talking, over $0.40, $0.40-$0.45.
Right. And that over $0.40, is that for an imported cell with U.S.-made module?
Actually, there is a blend. Basically, for this price, what we discussed with our customer is a blend of use of domestic and foreign imported cell.
Okay. Right. Because as you ramp up in 2028, your Humble cell facility, I got to imagine that that could be even mid to high $0.40 a watt for the U.S.-made cell and U.S. module, correct?
That is correct, Phil.
Yeah. Okay. Thanks. Then, maybe a couple more and I'll pass it on. As it relates to the onshoring offset plan, what's the latest timing on when you might receive news on a formal or official plan? The effective date of the polysilicon 232 tariff is December 4th. So, do you expect it before then, after then, or a coincidence? Thanks.
Yeah, I'll jump in here, Phil. In my conversations with Commerce, they're producing the guidance document for submitting plans. They expect it to come out this week. It went to the interagency last Monday, but they expect it to be published in the Federal Register this week. Again, they have no control at this point, so it might take a little bit longer. But that document would provide the guidance and the structure for people to submit their plans. Now, we've already done that, and we've had multiple conversations with them about specifically what our plan is, but we will still, as with everybody, have to submit in that format that they are requiring. We don't expect it to be radically different than what they did for pharmaceuticals, for example.
Our proposal is very much in line with what they're putting together at this point in time. They have not approved any plans at this point. They're having conversations with other companies. The feedback they've had with us is, "Hey, you guys are right at the front of the pack with a couple of others." But they probably won't be approving plans much before December 4th. They'll continue to happen through the first quarter of 2027 and beyond. But again, our goal here is to get certainty, and so we will be working very closely with Commerce, both after the guidance comes out, as well as broadly speaking with the team to make sure that they're comfortable with the structure we're using. Because again, as we mentioned, we're doing something that's a little bit different as a company.
We're importing our own cells and we're planning to onshore manufacturing in the U.S. in a fairly significant way.
Great. Thanks, Ryan. Last question from me. This is on margins. The margins in Q3 were much lower than we were expecting at 16% gross margins. How do you see them trending for Q4? And then how would you expect them to trend as you get up to higher volume in Q1, Q2, and Q3 next year, assuming the Ethiopia case goes in your favor? Thanks.
Do you want me to take this, Simon?
Simon, you want to take that one?
Yeah, sure. Thanks, guys. Phil, let me take this one. First of all, I think the slight drop of margin for Q3 really reflect the mix of the product category we sell. I mean, as Rhone mentioned, we slowed down the shipment from our cell factory in Q3, which lead to a higher percentage of our total sales coming from module in Q3. That explains why the overall margin level is lower than before. Speaking of Q4, we are hoping to get a preliminary results from Commerce regarding the circumvention, which will optimize our whole operation level in both Ethiopia and also in the U.S. But it's hard for us to make a comment at the moment.
Looking to 2027, like Rhone said, we have a strategy to address the circumvention investigation, and hopefully if Commerce follow their proceedings on the ruling and we can have a full resume of our operation from Ethiopia, and the margin will go back to close to the previous margin, which was more than 20%. Also, just to point on one thing here, even for our module manufacturer inside the U.S. in Houston, our margin is double digit. Our margin for module is also double digit, Phil.
I think that's a really important point, Trent.
I also want to clarify that the Q3, I don't believe, had any contribution from 45x and how that could change things in the future.
That's correct. That's very relevant inputs, Crocker. Actually, I think there was no contribution from ever whatsoever any 45x in Q3, in the Q3 margin, in the Q3 overall performance financial number. We are happy to tell you that actually our first offset from the tax credit of last year has been approved. This is a significant movement for our 45x qualification, Phil.
Yeah, so combined-
Going forward, I believe this is going to be. Rowan, please go ahead.
Well, I was going to say, just combined, Phil, when you think about it, if our margins are mostly driven this quarter by module sales and we're still at 16.6%, and as Simon pointed out, we're double-digit margins for just producing modules, and that doesn't include 45x, that's some pretty efficient manufacturing that we have going on. Clearly, we get bigger margins from the cells, and once those open up, as Simon pointed out, we expect our margins to increase. But just looking at kind of the quarterly number, I think it's important to compare the fact that we were mostly module, and those margins are strong, and they don't include 45x yet. So, I would say a very successful number compared to many of the other manufacturers of modules.
Great. Thanks for the color, guys. I'll pass it on.
Thanks, Phil.
There are no further questions at this time. We have reached the end of the Q&A session. I will now hand the call back to Crocker for closing remarks.
Thanks so much to everybody. We appreciate you taking the time to join us on the call today. Please feel free to reach out to me with any questions for management that we couldn't cover on today's call. Or if you'd like to meet with management at the RE+ Solar Conference in Las Vegas this week, please let us know, or on their future investor trips to the U.S. Thanks again, and look forward to coming back to you to talk about fourth quarter. That's it, operator.
This concludes today's call. Thank you for attending. You may now disconnect.